Aspira Begin Period Cash Flow from 2010 to 2025

AWH Stock  USD 0.10  0.01  13.64%   
Aspira Womens' Begin Period Cash Flow is increasing with very volatile movements from year to year. Begin Period Cash Flow is estimated to finish at about 16.8 M this year. Begin Period Cash Flow is the amount of cash Aspira Womens Health has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. View All Fundamentals
 
Begin Period Cash Flow  
First Reported
2000-12-31
Previous Quarter
3.7 M
Current Value
962 K
Quarterly Volatility
16.6 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Aspira Womens financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aspira Womens' main balance sheet or income statement drivers, such as Depreciation And Amortization of 170.1 K, Interest Expense of 14.5 K or Selling General Administrative of 11.5 M, as well as many indicators such as Price To Sales Ratio of 4.5, Dividend Yield of 0.0094 or Days Sales Outstanding of 73.06. Aspira financial statements analysis is a perfect complement when working with Aspira Womens Valuation or Volatility modules.
  
Check out the analysis of Aspira Womens Correlation against competitors.

Latest Aspira Womens' Begin Period Cash Flow Growth Pattern

Below is the plot of the Begin Period Cash Flow of Aspira Womens Health over the last few years. It is the amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. Aspira Womens' Begin Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aspira Womens' overall financial position and show how it may be relating to other accounts over time.
Begin Period Cash Flow10 Years Trend
Very volatile
   Begin Period Cash Flow   
       Timeline  

Aspira Begin Period Cash Flow Regression Statistics

Arithmetic Mean15,836,101
Geometric Mean11,674,957
Coefficient Of Variation61.06
Mean Deviation7,582,939
Median16,631,000
Standard Deviation9,668,881
Sample Variance93.5T
Range37M
R-Value0.07
Mean Square Error99.6T
R-Squared0.01
Significance0.79
Slope145,664
Total Sum of Squares1402.3T

Aspira Begin Period Cash Flow History

202516.8 M
202412.2 M
202313.6 M
202237.4 M
202116.6 M
202011.7 M
20199.4 M

About Aspira Womens Financial Statements

Investors use fundamental indicators, such as Aspira Womens' Begin Period Cash Flow, to determine how well the company is positioned to perform in the future. Although Aspira Womens' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Begin Period Cash Flow12.2 M16.8 M

Currently Active Assets on Macroaxis

When determining whether Aspira Womens Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aspira Womens' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aspira Womens Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aspira Womens Health Stock:
Check out the analysis of Aspira Womens Correlation against competitors.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aspira Womens. If investors know Aspira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aspira Womens listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.15)
Revenue Per Share
0.714
Quarterly Revenue Growth
0.018
Return On Assets
(1.58)
Return On Equity
(7.23)
The market value of Aspira Womens Health is measured differently than its book value, which is the value of Aspira that is recorded on the company's balance sheet. Investors also form their own opinion of Aspira Womens' value that differs from its market value or its book value, called intrinsic value, which is Aspira Womens' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aspira Womens' market value can be influenced by many factors that don't directly affect Aspira Womens' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aspira Womens' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aspira Womens is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aspira Womens' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.